ArticleAnnals of translational medicine2017
Article in Annals of translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis.Scientific reports · 2020Pooled it
- BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications.Breast (Edinburgh, Scotland) · 2022Article
- Multiple imputation with missing data indicators.Statistical methods in medical research · 2021Article
- Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network.JNCI cancer spectrum · 2021Article
- Of Screening, Stratification, and Scores.Journal of personalized medicine · 2021Review
- The Relationship of Mutation Carriage ofEuropean journal of breast health · 2021Article
- A review of the endocrine resistance in hormone-positive breast cancer.American journal of cancer research · 2021Review
- Current practices on genetic testing in ovarian cancer.Annals of translational medicine · 2020Review
- Epithelial ovarian cancer risk: A review of the current genetic landscape.Clinical genetics · 2020Review
- Functional coding and non-coding variants in human BRCA1 gene and their use in genetic screening.Medical oncology (Northwood, London, England) · 2019Review
- Inequities in genetic testing for hereditary breast cancer: implications for public health practice.Journal of community genetics · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pathogenesis of breast cancer, the most frequent female malignancy, entails both genetic and acquired risk factors. Among the various oncogenetic mutations, those involving the BReast Cancer 1 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.